SCHEMBL23017953

SCHEMBL23017953

Cc1cc(OCCC(=O)O)cc(C)c1Cc1ccc(O)c(C(C)C)c1

nearest known ligand 0.79

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ THRB P10828 20/20 0.79
▸ THRA P10827 19/20 0.79

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sobetirome SCHEMBL29467327 0.88 THRB (1.00) THRBTHRA
Sobetirome SCHEMBL282119 0.88 THRB (1.00) THRBTHRA
SCHEMBL12642742 0.84 THRB (0.75) THRBTHRA
SCHEMBL282795 0.84 THRB (1.00) THRBTHRA
SCHEMBL22095710 0.84 THRB (0.91) THRBTHRA
SCHEMBL19655550 0.83 THRB (0.82) THRBTHRA
SCHEMBL3160844 0.83 THRB (0.71) THRBTHRA
SCHEMBL19920595 0.82 THRB (0.72) THRBTHRA
SCHEMBL19859395 0.82 THRB (0.80) THRBTHRA
SCHEMBL18028276 0.82 THRB (0.72) THRBTHRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3237605-B1 IMPROVEMENTS IN OLIGODENDROGLIAL CELL CULTURING METHODS AND IN METHODS FOR TREATING NEURODEGENERATIVE DISORDERS BY USING THYROID HORMONES OR ANALOGUES NEUORPHAN PTY LTD (AU) 2021-02-24 — — EP disclosed
Send feedback